Multiple reports indicate that CLA can reduce expression of TNF-α in the body, induce PPARγ receptor expression and inhibit the expression of NF-κB, thereby alleviating IBD symptoms [51, 52]. Here, NFKB1 is linked to inflammatory bowel disease.